Order Article Reprints

Wang K, Xiu M, Su X, Wu F, Zhang X. Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy. Antioxidants. 2022; 11(4):646. https://doi.org/10.3390/antiox11040646

Wang, Keqiang, Meihong Xiu, Xiuru Su, Fengchun Wu, and Xiangyang Zhang. 2022. "Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy" Antioxidants 11, no. 4: 646. https://doi.org/10.3390/antiox11040646

Wang, K., Xiu, M., Su, X., Wu, F., & Zhang, X. (2022). Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy. Antioxidants, 11(4), 646. https://doi.org/10.3390/antiox11040646